• For Institutions

  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Dec12
Berenberg Raises BioNTech's Target Price to $155
07:16
Dec10
Citi Analyst Maintains Buy Rating on BioNTech SE
10:26
BioNTech Maintains Strong Buy Rating on Positive Lung Cancer Phase III Data
02:36
Dec9
BioNTech SE and Bristol Myers Squibb Report Positive Mid-Stage II Results for Pumitamig in Advanced Triple-Negative Breast Cancer
12:00
Dec6
BioNTech and OncoC4 Announce Phase III Clinical Trial Results of Gotistobart for Lung Cancer
20:30
Dec4
Jefferies Maintains 'Buy' Rating on BioNTech with a Target of $151
21:23

Schedules & Filings

Schedules
Filings
Nov3
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 1.781 B, Net Income -33.66 M, EPS -0.1407

BioNTech SE (BNTX.US) Q3 2025 Earnings Conference CallBioNTech SE (BNTX.US) Q3 2025 Earnings Conference Call
Aug4
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 305.28 M, Net Income -452.53 M, EPS -1.8728

BioNTech SE (BNTX.US) Q2 2025 Earnings Conference CallBioNTech SE (BNTX.US) Q2 2025 Earnings Conference Call
May5
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 197.88 M, Net Income -450.1 M, EPS -1.8726

BioNTech SE (BNTX.US) Q1 2025 Earnings Conference CallBioNTech SE (BNTX.US) Q1 2025 Earnings Conference Call
View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
MSOX
7.940
+107.85%
+4.120
YCBD
1.200
+90.17%
+0.569
THH
15.520
+57.72%
+5.680
WEED
25.325
+55.65%
+9.055
NCI
1.920
+54.84%
+0.680
CNBS
34.820
+54.57%
+12.293
MSOS
5.800
+54.26%
+2.040
CGC
1.740
+53.98%
+0.610
RYM
23.800
+47.73%
+7.690
TLRY
12.150
+44.13%
+3.720
View More